Form 8-K - Current report:
SEC Accession No. 0001558370-24-010184
Filing Date
2024-07-25
Accepted
2024-07-25 16:15:10
Documents
14
Period of Report
2024-07-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enfn-20240719x8k.htm   iXBRL 8-K 45389
2 EX-10.1 enfn-20240719xex10d1.htm EX-10.1 66443
  Complete submission text file 0001558370-24-010184.txt   252035

Data Files

Seq Description Document Type Size
3 EX-101.SCH enfn-20240719.xsd EX-101.SCH 3257
4 EX-101.LAB enfn-20240719_lab.xml EX-101.LAB 16580
5 EX-101.PRE enfn-20240719_pre.xml EX-101.PRE 10713
16 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20240719x8k_htm.xml XML 5062
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 241142243
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)